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Abstract Dysregulation of intestinal epithelial cell per-
formance is associated with an array of pathologies whose
onset mechanisms are incompletely understood. While
whole-genomics approaches have been valuable for
studying the molecular basis of several intestinal diseases,
a thorough analysis of gene expression along the healthy
gastrointestinal tract is still lacking. The aim of this study
was to map gene expression in gastrointestinal regions of
healthy human adults and to implement a procedure for
microarray data analysis that would allow its use as a
reference when screening for pathological deviations. We
analyzed the gene expression signature of antrum, duode-
num, jejunum, ileum, and transverse colon biopsies using a
biostatistical method based on a multivariate and univariate
approach to identify region-selective genes. One hundred
sixty-six genes were found responsible for distinguishing
the five regions considered. Nineteen had never been
described in the GI tract, including a semaphorin probably
implicated in pathogen invasion and six novel genes.
Moreover, by crossing these genes with those retrieved
from an existing data set of gene expression in the intestine
of ulcerative colitis and Crohn’s disease patients, we
identified genes that might be biomarkers of Crohn’s and/
or ulcerative colitis in ileum and/or colon. These include
CLCA4 and SLC26A2, both implicated in ion transport.
This study furnishes the first map of gene expression along
the healthy human gastrointestinal tract. Furthermore, the
approach implemented here, and validated by retrieving
known gene profiles, allowed the identification of promis-
ing new leads in both healthy and disease states.
Introduction
The gastrointestinal (GI) tract is a complex system
characterized by multiple biological functions that are
anatomically distributed. Besides being the site for food
processing and nutrient absorption, it is also the largest
immune organ of the body and, being at the interface
with the external environment, constitutes an important
barrier against ingested pathogens and toxins. Further-
more, the intestine is the home of a large microbial
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community, roughly comprising 1014 cells, which is now
considered an additional metabolic organ of our body
(Backhed et al. 2005). These multiple functions signifi-
cantly rely on the epithelial cells. Given their ability to
integrate a large variety of environmental signals,
including those coming from the gut resident microbiota,
these cells are the main regulators of intestinal mucosal
homeostasis (Clavel and Haller 2007; McCole and Bar-
rett 2007). Hence, dysregulation of intestinal epithelial
cell performance is associated with an array of different
pathologies. For example, several studies have shown
that immune and epithelial cells concur with T-helper
cells in the pathophysiology of inflammatory bowel
disease (IBD) by undergoing phenotypic modifications
that mainly affect the maintenance of the epithelial
barrier. These modifications include reduced production
of a-defensins (Wehkamp et al. 2005), altered expression
of mucin genes (Buisine et al. 1999, 2001), expression of
IL-15 and TGFb (Yoshikai 1999), and dysregulation of
the pregnane X receptor target genes (Langmann et al.
2004). Also, it has been suggested that differences exist
in the phenotypic features of epithelial cells between
ulcerative colitis (UC) and Crohn’s disease (Andoh et al.
2001), although the onset mechanisms of these patholo-
gies are incompletely understood.
Global gene expression profile analyses of diseased
tissues greatly contributed to the understanding of how
deviation from healthy biological pathways may be asso-
ciated with specific phenotypes. These include neoplastic
diseases such as colorectal cancer (Reichling et al. 2005;
Sugiyama et al. 2005), celiac disease (Diosdado et al. 2004;
Juuti-Uusitalo et al. 2007), and idiopathic diseases such as
IBD (Csillag et al. 2007; Langmann et al. 2004; Moehle
et al. 2006). The interpretation of a pathology-related gene
expression signature relies on knowing the healthy profile.
Nonetheless, genomics approaches have seldom been used
for the study of the unaffected GI tract (Fleet 2007). Initial
studies conducted in rodents furnished a basic under-
standing of gene expression modulation along the healthy
GI tract. In a pioneer work, a gene expression analysis
based on a cDNA array representing about 8600 genes
showed that biological functions and gene expression are
highly correlated along the murine GI tract (Bates et al.
2002). Indeed, while some transcripts are commonly found
in different regions, distinct intestinal segments are char-
acterized by specific gene expression profiles (Anderle
et al. 2005; Fleet 2007; Mutch et al. 2004). Other studies
examined gene expression along the crypt-villus axis in the
small intestine and showed that a specific gene expression
program characteristic of intestinal epithelial cell matura-
tion also exists (Mariadason et al. 2005; Stegmann et al.
2006). On the other hand, less is known about how gene
expression is modulated in the healthy human GI tract. In
the large intestine, the existence of transcripts that are
specific to its different regions as well as of transcripts that
are gradually modulated longitudinally has been shown
(Glebov et al. 2003; Lapointe et al. 2008). The regional
character of gene expression in the large intestine could be
partially traced back to the different embryological origins
of its proximal and distal parts (Lapointe et al. 2008), but it
has also been suggested to play a role in the susceptibility
of the distinct colonic segments to different types of
colorectal carcinomas (Glebov et al. 2003).
To our knowledge, gene expression variation along the
cephalocaudal axis of the whole human gastrointestinal
tract has not been investigated. By analyzing gene
expression in biopsies taken from the stomach, duodenum,
jejunum, ileum, and transverse colon of healthy adults, this
study contributes to our understanding of gene expression
evolution along this system. Furthermore, this work
addresses how the generated profiles of gene expression
can be used as a reference when screening for pathological
deviations. The underlying assumption of current micro-
array studies is the belief that it is, in principle, possible to
fully describe a biological sample, a snapshot of a precise
physiological state, by a set of measures of gene expression
levels. In this context, the levels of mRNA that, for
example, Affymetrix probe sets account for can be inter-
preted as the descriptors of a given physiological state or
biological sample. This information is sometimes difficult
to exploit for the identification of specific targets or disease
biomarkers because of the large amount of noise intrinsic
to microarray analyses. Noise in this context can be related
to fluctuation due to the experimental conditions, to the
presence of outliers, and to genes presenting no modulation
between groups.
In this study we produced a map of gene expression in
different regions of the healthy human GI tract and
implemented a biostatistical method for noise filtering and
statistical significance assessment. This method is based on
the combination of a multivariate approach, principal
component analysis (PCA) for a first data compression and
signal extraction, and an univariate approach using robust
statistics for the estimation of statistical significance of the
selected genes. The built workflow furnishes a flexible but
robust way to extract knowledge to recognize significant
expression patterns with high confidence within the set of
the identified modulated genes.
By first identifying specific biomarkers of healthy
human gut segments and then by crossing them with genes
mostly affected in IBD we were able to identify both
interesting new leads such as novel ileal and colonic genes,
and promising candidate biomarkers of Crohn’s disease
and/or ulcerative colitis in ileum and/or colon.
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Materials and methods
Samples collection
Biopsies (10–15 mg) were collected by upper GI endos-
copy (with a pediatric colonoscope to reach the proximal
jejunum) and colonoscopy from the antrum, duodenum,
jejunum, ileum, and transverse colon (hereafter colon) of
two male and two female healthy human subjects recruited
in accordance with the Helsinki declaration and with pre-
vious approval by the Ethical Committee of the Canton de
Vaud, Lausanne, Switzerland. The individuals, informed
about the scope of the study, were between 20 and
30 years, did not have any gastrointestinal or cardiovas-
cular disorder, did not use any drugs during the 4 weeks
before sampling, and were Helicobacter pylori negative.
Study participants were required to fast for 12 h and were
given a bowel preparation (Fordtran’s and Cololyt solu-
tions) to prepare the intestine the evening before endos-
copy. All endoscopic procedures were performed by a
gastroenterologist at the University Hospital of the Canton
de Vaud (CHUV), Lausanne, Switzerland. The biopsies,
which were expected to mainly contain mucosal tissue,
were snap-frozen and stored at –80C until use (within
2 weeks from sampling).
RNA isolation and gene array hybridization
Total RNA was extracted using the TriPure Isolation reagent
(Roche Diagnostics AG, Rotkreuz, Switzerland) and Dnase-
I treated and purified with the Nucleospin kit (Macherey-
Nagel AG, Oensingen, Switzerland). RNA quality was
assessed with the Agilent 2100 Bioanalyzer and the RNA
6000 Nano Chip kit (Agilent Technologies, Waldbronn,
Germany). RNA (5 lg) from each sample was then inde-
pendently amplified, labeled, and hybridized to the HG-
U133A Affymetrix chip (Affymetrix, High Wycombe, UK),
according to the manufacturer’s instructions. The chips were
scanned at 488 nm with an argon-ion laser (Agilent Bio-
technologies and Affymetrix) and expression signals were
generated and normalized using the MAS 5.0 algorithm
(Affymetrix). All chips used in this study were processed in
line with and passed the quality control steps built in the
Affymetrix standard procedure for gene array hybridization,
including spiking with a prokaryotic control cocktail to
assess hybridization performance. The entire data set has
been deposited at the NCBI Gene Expression Omnibus
(GEO) repository (http://www.ncbi.nlm.nih.gov/geo/)
under accession number GSE10867. Gene expression of the
samples was not investigated with any additional technique
since microarray measurements have been shown to be
reproducible across different platforms and therefore they
can be used independently (Chou et al. 2008; Shi et al. 2006).
Identification of region-selective biomarkers
After a preprocessing step, including normalization
(MAS 5.0, Affymetrix) and log transformation of the
hybridization signals, the data were organized into a
matrix of 20 rows and 22,283 columns, corresponding
to the number of arrays (each representing a biological
sample of one of the five gut compartments labeled
according to the gender of the corresponding individual)
and the number of probe sets (variables), respectively.
To check for intrinsic clustering among the 20 biolog-
ical samples, unsupervised PCA and hierarchical clus-
tering (HCA; Ward’s method, Euclidean metric)
analysis were performed. Region-specific gene bio-
markers were identified based on the loadings that
describe the relative contributions of the probe sets’
effect on the decomposition of the data. In a second
stage, loadings (for probe sets) and scorings (for sam-
ples) were mapped onto a biplot to determine region-
specific gene regulation. The selected genes were then
crossed with the highly variable ones identified in the
GSE1152 data set, publicly available at the GEO
repository. All analyses were performed using R Soft-
ware and Bioconductor packages (Gentleman et al.
2004). The statistical significance of differential gene
expression was determined using a modified ANOVA
according to the Global Error Assessment procedure
(Mansourian et al. 2004). Finally, to bypass the problem
of multiple Present (P) and Absent (A) calls for the
same gene/condition, we computed a virtual chip using
the robust average of the probe sets’ values of the same
gene in the different chips and then computed the P/A
calls using the Affymetrix MAS 5.0 algorithm.
Bioinformatics analyses
Probe sets were annotated using ENSEMBL v28 and
NetAffx (Affymetrix) (grade 1), preferring the former if
discordant (grade 2) or the latter if the former was missing
(grade 3). Probe sets representing unknown sequences were
tentatively annotated (grade 4) by protein domain recog-
nition analysis using HMMer against Pfam (http://pfam.
sanger.ac.uk/) and with PSI-Blast (Altschul et al. 1997).
The level of confidence of the annotation was expressed as
an E value, i.e., the probability of detecting the similarity
by chance, as calculated by PSI-Blast (cutoff = 10E-5).
Gene expression profiles were represented using Spotfire
Decision Site for Functional Genomics 7.3 (TIBCO Spot-
fire Inc., Palo Alto, CA). An automated literature search
based on WordStat v4.0.19 and SimStat v2.5.1 software
(Provalis Research, Montreal, CA), followed by manual
refinement, was used to identify genes that had never been
described in the GI tract.
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Results and discussion
Global analysis of the gastrointestinal tract
transcriptome
Total mRNAs prepared from the biopsies of antrum, duo-
denum, jejunum, ileum, and colon of two males and two
females were independently hybridized to the Affymetrix
gene chip U133A, which contains 22,283 probe sets
representing 14,593 UniGene clusters for a total of
20 microarrays used. Villin (205506_at), occludin
(209925_at), and the transcription factor Elf3 (201510_at),
three genes expressed exclusively in the epithelium, were
scored present and highly expressed in all regions. On the
other hand, CD80 (207176_s_at), CD86 (205685_at), and
CD14 (201743_at), expressed in immune cells, and epi-
morphin (207346_at), expressed in mesenchymal cells,
were scored absent and/or with very low hybridization
intensities. Therefore, we can assume that the expression
profiles produced in this study represent mainly epithelial
cells. A blind unsupervised approach was used to assess the
samples’ separability while reducing the amount of noise
by complementing PCA and HCA analyses. The repre-
sentation of the data on the two first principal components
clearly showed two possible outliers, one from antrum
gathering with ileum samples and one from ileum gather-
ing with jejunum samples (data not shown). These two
samples were removed from further analysis since devia-
tion of a single representative point from the cluster of its
peers, at a distance as great as ten times the standard
deviation of the related cluster, seemed suspicious, and the
chance of this representing a real biological effect was
estimated to be vanishing. HCA and PCA performed on the
remaining 18 samples gave consistent and overlapping
results and provided the basis to further restrain the anal-
ysis to those probe sets, out of the original 22,283, that
varied most significantly among them. A magnitude of
every probe set contribution was estimated and the original
data set was reduced to 199 significant probe sets (Sup-
plementary Table 1). These probe sets, selected on the
basis of their important loadings (high loading corresponds
to high variance), are those mainly contributing to the
observed intracluster energy and therefore are responsible
for sample separation. When carrying out HCA and PCA
on these probe sets, we found that samples were not sep-
arable according to gender but were rather clearly stratified
according to the gastrointestinal region (Fig. 1a, b). PCA
was able to capture more than 85% of the information
contained in the raw data set. Sample separation was par-
ticularly evident for antrum, colon, and ileum, while duo-
denum and jejunum were somewhat more similar. This was
further highlighted by analyzing the region-specific mod-
ulation of the 199 selected probe sets through scorings and
loadings mapping on a biplot (Fig. 1c). Thirty-eight probe
sets were modulated in antrum, 20 in ileum, and 33 in
colon. The identification of probe sets selective of duode-
num and jejunum turned out to be more difficult. Of a total
of 108 probe sets specifically modulated in these two
compartments, we could identify 21 probe sets in duode-
num and 15 in jejunum, while the remaining 72 were
jointly modulated in both tissues. No probe set expressed in
all regions but one was found. All of the 199 probe sets
were found to be statistically significantly differentially
expressed by using the Global Error Assessment (GEA)
model (P \ 0.001), except for 220038_at which was
therefore excluded from further examination.
Identification and expression analysis of healthy
intestinal regions’ selective genes
The 198 probe sets selected above were assigned to 166
unique genes (Fig. 2) that we defined as region-selective
but not necessarily region-specific, with some expressed in
more than one GI segment according to Affymetrix present
calls (Supplementary Table 1). Region-selective genes are
preferentially, but not exclusively, expressed in a given
region and are likely to be involved in its major physio-
logical functions. Region-specific genes are restricted to
that region and may be used to distinguish it (Hsiao et al.
2001). Automated literature mining followed by manual
refinement was used for the 166 genes to discriminate
between novel and existing information. One hundred
sixteen genes were found to be associated with known
intestinal functions and their expression profile corre-
sponded to previously reported data. In particular, the
expression profile of most of these genes reflected intesti-
nal biological functions that are anatomically distributed,
including digestion in the upper regions and absorption and
excretion in the middle and lower parts of the GI tract. This
validated our gene-selection approach and these genes
were not further investigated. Thirty-one genes had already
been described in the GI tract but their proximal-to-distal
profile had not been documented. These are NMU, MUC1,
MUC6, FOXA2, GATA4, ORM1, and CRIP2 selective of
antrum; TM4SF4 and SERPINB5 selective of duodenum;
GPR172B, SFRP5, HTR1D, BST1, and RASA4 selective
of duodenum and jejunum; CLDN15 selective of jejunum;
UGT2B17, CFTR, MUC2, ZG16, and PPP1R12A selective
of ileum; and PDE9A, HOXA9, HOXA6, PYGB, POSTN,
CEACAM5, CD24, TSPAN-1, CNNM4, HK2, and RAR-
RES1 selective of colon. Finally, 19 genes had never been
reported in the human GI tract. These include SEMA6A, a
semaphorin involved in the control of actin filament
dynamics (Klostermann et al. 2000) and possibly in path-
ogen invasion (Laurent et al. 1999) and found to be ileum-
selective; PCDH21, a cadherin suggested to be involved in
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the formation of neuronal networks in the olfactory bulb
(Nakajima et al. 2001) and found to be colon-specific;
MS4A12, a member of the membrane-spanning 4A family
thought to be involved in signal transduction (Liang and
Tedder 2001) which is colon-specific; CLIC3, a nuclear
chloride channel found to be specific of antrum; and
CLCA4, a Ca2?-activated chloride channel which is colon
selective. Six of the 19 genes were unknown genes that
were tentatively annotated as explained in Materials and
methods. Among these we identified, based on protein
sequence analysis, FLJ22880 as a new putative member
(E = 3.8e-134) of the L6 family of transmembrane proteins
(Maecker et al. 1997; Wright et al. 2000) that is selective of
small intestine and likely to be implicated in signal trans-
duction events, and a dihydroxyacetone kinase (DAK-1,
E = 7.5e-128; DAK-2, E = 4.3e-69) that catalyzes the first
limiting step of glycerol utilization (glycerone to glycerone
phosphate, KEGG map00561, http://www.genome.jp/kegg/)
Fig. 1 Clustering of gastrointestinal regions’ transcriptomes based on
the 199 probe sets responsible for sample separability. Principal
components analysis (PCA) (a) and hierarchical clustering (Ward’s
method) (b) analysis were conducted on the 18 samples, each
individually represented on the graphs. The scale of b is the sum of
the squares of the euclidean distance (the unit) for the cluster and it is
based on a differential matrix. Consistency between A (PCA) and B
supported the tree which was generated by hierarchical clustering.
The scorings (samples) and loadings (probe sets) from PCA analysis
were then mapped on the same plot, called a biplot (b). As a
consequence of the matrix factorization X (log transformed and
centered on 0), the modulation of any probe set can be geometrically
inferred from its position on the biplot. Accordingly, when a probe set
lies far from the origin and close to one chip, it is upregulated in this
chip (gastrointestinal segment sample) compared to all the others and
vice versa. The highest the distance of a probe set from the origin, the
highest its modulation. The magnitude of modulation for each probe
set is given as a numerical value (Norm value, Fig. 2). A antrum, D
duodenum, J jejunum, I ileum, C colon
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and that has not yet been characterized in human and has
been found to be selective of proximal small intestine. A
putatively novel transcription factor containing JmjC
domains (FLJ13798, E = 7.8e-05) was identified as
selective of proximal small intestinal regions but has not
been further investigated since it was called absent by the
Affymetrix algorithm. The colon-specific probe set
220724_at was assigned to a nuclease/phosphatase which,
despite the low level of confidence (E = 0.16), was con-
firmed by fold recognition analysis (not shown). Finally,
two probe sets (214046_at and 220645_at) remained
unassigned, although the gene represented by 220645_at is
called 99% similar to a brush border protein gene
belonging to the same UniGene cluster. Based on Uni-
Gene’s EST Profile Viewer, these 19 genes indeed were
confirmed to be expressed in the GI segment to which they
were found to be associated, except for CLIC3, FLJ13798,
CML2, and SEMA6A for which complete information was
not available.
Subsequent particular analysis of gene expression
modulation showed that the antrum was characterized by
the modulation of genes encoding for several gastric pro-
teins such as trefoil factors, progastricsin, and mucin 5AC
(Fig. 2a), as well as a gene encoding for the cytosolic
sulfotransferase SULT1C1, a finding supported by previous
research reporting sulfotransferase activity in the antral and
body mucosa of human and rat stomachs. This enzyme
catalyzes the transfer of a sulfate ester group from 30-
phosphoadenosine 50-phosphosulfate to the carbohydrate
chain of gastric mucus glycoproteins (Carter et al. 1988;
Liau et al. 1983). Another important finding was the
identification of the b-microseminoprotein isoform-a pre-
cursor. This is a small disulfide-rich protein with unknown
function that is present in the secretions of most mucosal
surfaces in the body, including the stomach where it is
secreted in the antrum by endocrine cells (Weiber et al.
1997). The protein has been investigated as a biomarker of
gastric carcinoids (Weiber et al. 1999).
Fig. 2 Proximal-to-distal expression pattern of 166 region-selective
genes along the GI tract. The 199 probe sets responsible for sample
clustering (Fig. 1) were found to correspond to 166 genes selective of
a antrum (36 genes); b duodenum (14 genes), duodenum and jejunum
(57 genes), and jejunum (14 genes); c ileum (16 genes) and colon (29
genes). Their expression pattern along the gastrointestinal tract is
visualized in the heat map that was constructed using the ln-
transformed average hybridization intensities calculated from three to
four replicates (individuals). The gene description corresponds to the
ENSEMBL and Affymetrix designation (grade 1), ENSEMBL only
(grade 2), and Affymetrix only (grade 3), or was tentatively assigned
as explained in the text (grade 4). The normalization (Norm) value,
calculated by PCA, represents the importance of each gene in
distinguishing the related gut segment from the others; values close to
or higher than 2 correspond to high tissue selectivity. Bold indicates
genes not previously described to be expressed in the corresponding
gut region based on automated literature search, as explained in
Materials and methods. A antrum, D duodenum, J jejunum, I ileum, C
colon, na not applicable
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Fig. 2 continued
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The whole experimental approach was clearly validated
by finding that the unique probe set on the HG-U133A Af-
fymetrix chip that was annotated to be antrum-specific was
retrieved as being specifically modulated in this same region
(probe set ID: 220191-at). The duodenum and jejunum
(Fig. 2b) were characterized by the modulation of a large
spectrum of proteolytic enzymes, a number of lipoprotein
precursors, and several solute carrier proteins (transporters).
A number of detoxifying enzymes that belong to the cyto-
chrome P450 family were also modulated in these regions. In
what concerned duodenum tissue only, modulation of the
NPC1 gene was found remarkable. A deficiency in the
function of this gene is related to the Niemann-Pick disease
type C that is due to defective cholesterol intracellular
transport (Liscum and Klansek 1998). The jejunum was
characterized by peptido- and glycohydrolytic activities due
to the specific modulation of the related enzymes such as
dipeptidylpeptidase, aminopeptidase, glucoamylase, and
isomaltase. Several interesting genes appeared to be modu-
lated in both duodenum and jejunum, such as vanin-1, which
is involved in the biosynthesis of vitamin B (Martin et al.
2004), and sterolin-1, which prevents dietary noncholesterol
sterols from being absorbed (Klett and Patel 2003). Among
genes selective of ileum (Fig. 2c), we found MUC2, which
codes for a mucin associated with high colonic expression
(Tytgat et al. 1994). Analysis of the corresponding probe set
position on the biplot (Fig. 1c) revealed that it is almost
equidistant from ileum and colon, highlighting similar
expression in the two regions. Accordingly, mucin 2, besides
being dominant in colon mucins, could also be one of the
main ileal mucins. An important novelty came from scrutiny
of other genes selective of ileum, as we found evidence for
the important modulation of semaphorin 6A1, a protein
involved in neuronal development and regeneration during
apoptosis that is discussed further below. The colon (Fig. 2c)
was characterized by an elevated modulation of genes
encoding for carbonic anhydrase precursors as well as for
carcinoembryonic antigen-related cell adhesion molecules.
Few other genes appeared to be modulated, e.g., aquaporin
and the osteoblast specific factor 2.
Our analysis was validated once more by the finding of
the known differential expression of the claudin family of
Fig. 2 continued
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tight junction proteins involved in paracellular transport
(Rahner et al. 2001). For instance, the expression of claudin
4 was found to be highly restricted to the colon, whereas
claudin 18 was mainly expressed in the antrum. Knowledge
of these expression patterns is significant as it has been
proposed that they underlie differences in the paracellular
permeability properties (Niimi et al. 2001).
Among novel genes and genes not previously known to
be expressed in the GI tract, we found several transmem-
brane proteins that seem to be important to gut regions in a
specific manner. These include SEMA6A, FLJ22800,
TSPAN1, and MS4A12. This has possible implications in
the recognition of non-self molecules such as nutrients,
pathogenic and commensal bacteria, or any other antigen,
and subsequently generated signaling events in the entero-
cyte. For example, it has been suggested that SEMA6A
plays a role in retrograde signaling to cytoskeletal elements
by regulating proteins like Ena/VASP (Klostermann et al.
2000). Interestingly, these proteins mediate intracellular
movement of L. monocytogenes by linking the bacterium to
the actin tail (Laurent et al. 1999); therefore, semaphorin 6A
may play a role in pathogen infection in the small intestine.
We suggest that FLJ22800 is a new L6 type of protein,
based on protein sequence analysis. L6 proteins are surface
proteins characterized by four transmembrane domains and
constitute a family of four members: L6, IL-TMP, TM4SF5,
and L6D (Wright et al. 2000). The biological function of
these proteins is not completely understood, although they
have been implicated in signal transduction events. More-
over, it has been suggested that they mediate tumor cell
metastasis and cell adhesion (Kao et al. 2003). All except
L6D are represented on the Affymetrix U133A chip used in
this study so we could therefore examine their expression
pattern. They all appear to have very low expression in
colon and enriched expression in the proximal small intes-
tine. It is notable that IL-TMP has been identified in this
study as a descriptor of duodenum. TM4SF5 is the only one
expressed in the antrum, while L6 seems to be the only one
not expressed in the GI tract, even though this should be
confirmed by independent assays. L6 proteins were previ-
ously considered to be tetraspanins (Maecker et al. 1997;
Marken et al. 1992) because of their similar topological
features. Tetraspanins are transmembrane proteins that
support and stabilize the formation of signaling complexes
(Maecker et al. 1997). The expression of several tetraspa-
nins as well has been shown to be highly regulated along the
GI tract (Okochi et al. 1999). We found TSPAN1 (trans-
membrane protein tetraspanin-1) to be a gene selective of
colon. Of all members of the tetraspanin family, TSPAN-1
is most similar to CD81 (Todd et al. 1998), which is
expressed in olfactory neurons. The specific role of
TSPAN-1 in colon is still unknown. Finally, MS4A12 is a
member of the membrane-spanning 4A gene family, whose
expression pattern and biological role are unknown even
though it has been suggested to be involved in signal
transduction, as are the other family members (Liang and
Tedder 2001). The high expression level and modulation
value in colon, as well as the fact that no ESTs have been
found in any tissue but colon, suggest that this gene is
colon-specific.
Taken as a whole, these data represent the first mapping
of the healthy adult human gastrointestinal transcriptome.
Identification and expression pattern analysis of ileum
and colon selective genes in IBD
To show the effective use of our approach when studying
gene expression deviation in gut pathologies, we reanalyzed
the GEO data set GSE1152 that contains gene expression
profiles corresponding to the ileum and colon of Crohn’s,
ulcerative colitis (UC), and control patients (Langmann
et al. 2004). In that study, the same microarray platform
used here was employed. First we explored regional clus-
tering in the IBD condition by applying the approach
described above. We carried out a global analysis of the
data using the 22,283 probe sets and all the samples crossing
the regions (ileum and colon) and conditions (healthy,
Crohn’s, and UC). We reduced the original data set to only
the significant probe sets (329) using their magnitudes.
When performing PCA on this subset we were able to see a
clear stratification according to the disease rather than to the
region type (Fig. 3), which confirmed previous observations
(Langmann et al. 2004). This withstanding, the gene
expression profile in ileum from UC patients tends to
approach that of the control samples, which shows that the
transcriptome of this organ is only slightly affected by this
disease compared to transverse colon. Finally, 37 of the 45
genes found to be selective of the healthy ileum and colon in
our data set (Fig. 2) were modulated in the IBD state, with
an absolute fold higher than 1.5 (Supplementary Table 2).
Next, we carried out a more detailed analysis by region and
by disease. Because we lacked replicates from the GSE1152
data set since samples had been pooled per condition, we
were not able to select probe sets statistically; therefore, we
took into account the expression level and the density of the
probe sets and selected the highly modulated ones, both by
intestinal region and by disease, using a binning and
skimming technique. We constructed a plot of the log2fold
(disease/healthy) versus the mean log2expression, thus
identifying highly variable probe sets independent from the
level of expression. These probe sets were then crossed with
the 199 descriptor probe sets identified by our previous
analysis (Fig. 1, Supplementary Table 1). The genes thus
selected are represented in Fig. 4.
The ‘‘by region’’ analysis (Fig. 4, spots) shows that both
Crohn’s and ulcerative colitis modulate gastrokine 1
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(GKN1) and mucin5AC (MUC5AC) in ileum and calcium-
activated chloride channel 4 (CLCA4) and mucin5B
(MUC5B) in colon. The ‘‘by disease’’ analysis (Fig. 4,
dotted grid) shows that none of the region-specific bio-
marker genes is modulated by Crohn’s disease in both ileum
and colon, while peptide YY (PYY) is jointly modulated by
colitis in both regions. Specifically modulated genes include
mucin and cadherin like (MUCDHL) and G protein-coupled
receptor family C group 5 member B (GPRC5B) down-
regulated in Crohn’s ileum, liver fatty acid binding protein
L-FABP downregulated in colitis ileum, sulfate transporter
(SLC26A2) and carcinoembryonic antigen-related cell
adhesion molecule 7 (CEACAM7) upregulated in Crohn’s
colon, tetraspanin-1 (TSPAN-1) downregulated in Crohn’s
colon, and finally glycogene phosphorylase brain form
(PYGB) and gastrotropin or ileal fatty acid binding protein
(ILBP) downregulated in colitis colon. Interaction network
analysis suggested that these genes are more likely to be
involved in independent biological pathways (data not
shown). CEACAM7 is a member of the carcinoembryonic
antigen (CEA) family and is found only at the apical surface
of highly differentiated epithelial cells in the colorectal
mucosa (Scholzel et al. 2000). Interestingly, its expression
correlates with apoptosis in the normal colon. Increased
gene expression in inflamed compared to healthy epithe-
lium may therefore relate to an alteration of the apoptotic
pathway accompanied by increased apoptosis, which has
recently been suggested to be implicated in the IBD
pathology (Verstege et al. 2006). Moreover, The Ca2?-
activated chloride channel 4 (CLCA4), which we had found
to be the main discriminator of the healthy colon (highest
Norm value, Fig. 2), is supposed to upregulate the trans-
membrane potential and mediate secretion of electrolytes
and water (Eggermont 2004). Its upregulation in Crohn’s
and UC patients may be related to the onset of diarrhea
resulting from increased Cl- secretion. Finally, PYGB, a key
enzyme in glycogen degradation involved in calcium and
insulin signaling, has been identified in colon. PYGP is not
detected in any other region examined in this study and is a
strong colon classifier (Norm value = 1.83, Fig. 2). This
gene has been proposed to be a marker of carcinogenesis
(Tashima et al. 2000). Since IBD patients are at higher risk
of developing colorectal cancer, the identification of this
gene as a descriptor of UC in colon may be diagnostically
relevant.
In summary, PCA could differentiate between the tran-
scriptomes from Crohn’s patients and those from colitis
and healthy patients based on the selected 329 genes. This
withstanding, when looking for descriptors of each region-
disease association, we found both genes specific to each of
the conditions considered and genes commonly modulated
in both diseases and regions (except for ileum and colon of
Crohn’s patients).
Conclusions
This study provides the first map of gene expression in
various compartments of the healthy human adult gastro-
intestinal tract and a biomathematical information com-
pression approach for the selection of longitudinally
differentially expressed genes. The analysis uncovered clear
differences in the levels of gene expression among the five
Fig. 4 Genes associated with ulcerative colitis (UC) and/or Crohn’s
disease in the ileum and/or colon. Genes were identified by a ‘‘by
region’’ (ileum and colon) and a ‘by disease’’ (UC and Crohn’s)
analysis, as explained in the text. Solid and dashed boxes indicate
genes associated with UC and Crohn’s, respectively. Genes in the
spots area were modulated in one of the two regions in both diseases,
and genes in the dotted grid area were modulated in both regions in
one of the diseases. Arrows indicate up- and downregulation
Fig. 3 Clustering of healthy and inflamed ileum and colon tran-
scriptomes. PCA was conducted on the Affymetrix expression data
obtained from the healthy and affected ileum and transverse colon of
Crohn’s and ulcerative colitis patients (data from the GEO data set
GSE1552) using the 329 most significant genes (i.e., the genes
preselected by PCA to be responsible for samples separability). I
ileum, C colon, Con control, Cro Crohn’s, Col colitis
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regions under scrutiny in the healthy condition. In particu-
lar, it allowed differentiation between the transcriptomes of
duodenum and jejunum, which had not been possible in a
previous study of gene expression in the murine healthy GI
tract (Bates et al. 2002). Furthermore, the approach was
applied to an existent data set of gene expression in the
intestine of patients affected by Crohn’s disease and
ulcerative colitis, two manifestations of inflammatory
bowel disease. We were therefore able to identify interest-
ing new leads in both the healthy and the disease state.
These data furnish a basis for understanding the complex
role played by the intestinal epithelium in the maintenance
of intestinal homeostasis.
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